{"mainPropery":{"diseaseId":5194,"diseaseName":"Idiopathic thrombocytopenic purpura","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/5194/idiopathic-thrombocytopenic-purpura","synonyms":["ITP","Autoimmune thrombocytopenic purpura","Thrombocytopenic purpura autoimmune"],"synonyms-with-source":[{"name":"ITP"},{"name":"Autoimmune thrombocytopenic purpura"},{"name":"Thrombocytopenic purpura autoimmune"}],"identifiers":[{"identifierType":"OMIM","identifierId":"188030"},{"identifierType":"ORPHANET","identifierId":"3002"},{"identifierType":"UMLS","identifierId":"C0043117"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"}],"organizations":[{"resourceID":205,"resourceName":"National Blood Clot Alliance","abbreviation":"","address1":"8321 Old Courthouse Road","address2":"Suite 255","address3":"","address4":"","address5":"","city":"Vienna","state":"VA","zip":"22182","country":"United States","phone":"+1-703-935-8845","tty":"","tollFree":"1-877-466-2568 (877-4NO-CLOT)","fax":"","email":"info@stoptheclot.org","url":"https://www.stoptheclot.org/","freeText":""},{"resourceID":248,"resourceName":"Platelet Disorder Support Association","abbreviation":"","address1":"8751 Brecksville Road","address2":"Suite 150","address3":"","address4":"","address5":"","city":"Cleveland","state":"OH","zip":"44141","country":"United States","phone":"440-746-9003","tty":"","tollFree":"87-PLATELET (1-877-528-3538)","fax":"844-270-1277","email":"pdsa@pdsa.org","url":"http://www.pdsa.org/","freeText":""},{"resourceID":401,"resourceName":"Vascular Cures","abbreviation":"","address1":"274 Redwood Shores Parkway, #717","address2":"","address3":"","address4":"","address5":"","city":"Redwood City","state":"CA","zip":"94065","country":"United States","phone":"+1-650-368-6022","tty":"","tollFree":"","fax":"","email":"info@vascularcures.org","url":"https://vascularcures.org/","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/188030' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=Idiopathic+thrombocytopenic+purpura%5Bti%5D+AND+%28%222003%2F10%2F13%22%5BPDat%5D+%3A+%222008%2F10%2F10%22%5BPDat%5D+AND+%28Clinical+Trial%5Bptyp%5D+OR+Meta%2DAnalysis%5Bptyp%5D+OR+Practice+Guideline%5Bptyp%5D+OR+Randomized+Controlled+Trial%5Bptyp%5D+OR+Review%5Bptyp%5D%29%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Idiopathic thrombocytopenic purpura. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Idiopathic+thrombocytopenic+purpura%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Idiopathic thrombocytopenic purpura. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0043117' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/258/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000535.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/med/TOPIC1151.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=3002' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1538,"resourceId":2169,"resourceName":"MeSH®","descriptionText":"<a href='https://meshb.nlm.nih.gov/record/ui?ui=D016553' target='_blank'>MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1558,"resourceId":2184,"resourceName":"National Heart, Lung, and Blood Institute","descriptionText":"The <a href='http://www.nhlbi.nih.gov/health/dci/Diseases/Itp/ITP_WhatIs.html' target='_blank'>National Heart, Lung, and Blood Institute</a> (NHLBI) has information on this topic. NHLBI is part of the National Institutes of Health and supports research, training, and education for the prevention and treatment of heart, lung, and blood diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:188030' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/idiopathic-thrombocytopenic-purpura' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Idiopathic thrombocytopenic purpura. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Idiopathic thrombocytopenic purpura:<br />\r\n<a href='https://itpstudy.iamrare.org/' target='_blank'>ITP Natural History Study Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":1194,"questionText":"What is idiopathic thrombocytopenic purpura?","answerText":"<strong>Idiopathic thrombocytopenic purpura (ITP)</strong> is a bleeding disorder characterized by too few <a href=\"http://www.ouhsc.edu/platelets/platelets/platelets%20intro.html\" target=\"_blank\">platelets</a> in the blood. This is because platelets are being destroyed by the <a href=\"http://kidshealth.org/parent/general/body_basics/immune.html\" target=\"_blank\">immune system</a>. Symptoms may include bruising, nosebleed or bleeding in the mouth, bleeding into the skin, and abnormally heavy <a href=\"http://www.nlm.nih.gov/medlineplus/menstruation.html\" target=\"_blank\">menstruation</a>. With treatment, the chance of remission (a symptom-free period) is good. Rarely, ITP may become a chronic ailment in adults and reappear, even after remission.[704]","dateModified":"2016-06-06T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":34450,"abbreviatedInquiry":"Is&nbsp;idiopathic thrombocytopenic purpura hereditary?","caseQuestions":[{"questionId":4391,"questionText":"Can idiopathic thrombocytopenic purpura be inherited?","answerText":"The cause of&nbsp;idiopathic thrombocytopenic purpura (ITP) is unknown.&nbsp;It is not thought to be genetic because it is rare for multiple people in the same family to develop this disease.[3345] Only&nbsp;a few cases of familial&nbsp;ITP&nbsp;have been documented,&nbsp;including an affected woman&nbsp;and 3 of her 4 children, identical twins with chronic ITP, and&nbsp;a&nbsp;mother with chronic ITP who had a&nbsp;child with purpura. The child's purpura resolved on its own within 3 weeks while the mother remained thrombocytopenic.[3346]","dateModified":"2013-01-22T15:32:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3345,"authors":"B. Godeau ","articleTitle":"Immune thrombocytopenic purpura","bookWebsiteJournalTitle":"Orphanet","date":"August 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=3002","dateAccessed":"2012-03-22T00:00:00"},{"referenceId":3346,"authors":"Paul J. Converse et al","articleTitle":"THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP","bookWebsiteJournalTitle":"OMIM","date":"March 20, 2009","url":"http://www.ncbi.nlm.nih.gov/omim/188030","dateAccessed":"2012-03-22T00:00:00"}]}]},{"caseId":30487,"abbreviatedInquiry":"I was first diagnosed with idiopathic thrombocytopenic purpura, which then progressed to Evans syndrome. I had a splenectomy and have since been in remission. My husband and I have been together for 10 years, and in this time I have not conceived. Can Evans syndrome cause infertility? If I do get pregnant, would there be a chance my child could have the same condition?","caseQuestions":[{"questionId":4392,"questionText":"Can Evans syndrome cause infertility?","answerText":"A review of available literature does not yield any information or case reports regarding Evans syndrome and infertility. Furthermore, infertility is not mentioned as being a sign or symptom of Evans syndrome in various resources.<br />\r\n<br />\r\nEvans syndrome appears to be rare in pregnancy with only a few published cases. Because some of the medications used to treat Evan's syndrome may be harmful to a developing baby, treatment options in pregnancy can be limited. However, women with Evans syndrome can have successful pregnancies.[3347]","dateModified":"2014-11-16T00:00:00","references":[{"referenceId":3347,"authors":"Lefkou E, Nelson-Piercy C, Hunt BJ","articleTitle":"Evans' syndrome in pregnancy: a systematic literature review and two new cases","bookWebsiteJournalTitle":"European Journal of Obstetrics, Gynecology, and Reproductive Biology","date":"March 2010","volume":"149(1)","pages":"10-17","url":"http://www.ncbi.nlm.nih.gov/pubmed/20031296","dateAccessed":"2011-04-24T00:00:00"}]},{"questionId":4391,"questionText":"Can idiopathic thrombocytopenic purpura be inherited?","answerText":"The cause of&nbsp;idiopathic thrombocytopenic purpura (ITP) is unknown.&nbsp;It is not thought to be genetic because it is rare for multiple people in the same family to develop this disease.[3345] Only&nbsp;a few cases of familial&nbsp;ITP&nbsp;have been documented,&nbsp;including an affected woman&nbsp;and 3 of her 4 children, identical twins with chronic ITP, and&nbsp;a&nbsp;mother with chronic ITP who had a&nbsp;child with purpura. The child's purpura resolved on its own within 3 weeks while the mother remained thrombocytopenic.[3346]","dateModified":"2013-01-22T15:32:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3345,"authors":"B. Godeau ","articleTitle":"Immune thrombocytopenic purpura","bookWebsiteJournalTitle":"Orphanet","date":"August 2009","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=3002","dateAccessed":"2012-03-22T00:00:00"},{"referenceId":3346,"authors":"Paul J. Converse et al","articleTitle":"THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP","bookWebsiteJournalTitle":"OMIM","date":"March 20, 2009","url":"http://www.ncbi.nlm.nih.gov/omim/188030","dateAccessed":"2012-03-22T00:00:00"}]},{"questionId":7915,"questionText":"Is Evans syndrome inherited?","answerText":"While Evans syndrome is not thought to be inherited in most cases and rarely occurs in more than one person in a family, there are a few cases in the medical literature describing \"familial Evans syndrome.\" The majority of familial cases involve siblings that are found to have Evans syndrome. Some of these cases were additionally associated with other symptoms, such as heart defects as well as other disorders that are known to be inherited, such as <a href=\"https://rarediseases.info.nih.gov/gard/6637/hereditary-spastic-paraplegia/resources/1\" target=\"_blank\">hereditary spastic paraplegia</a>.[7879][7880][7881]<br />\r\n<br />\r\nIf there is a family history of Evans syndrome, we would recommend consulting with a genetics professional to discuss risks for family members.&nbsp;","dateModified":"2016-07-28T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":7879,"authors":"Ahmed FE, Albakrah MS","articleTitle":"Neonatal familial Evans syndrome associated with joint hypermobility and mitral valve regurgitation in three siblings in a Saudi Arab family.","bookWebsiteJournalTitle":"Ann Saudi Med","date":"May 2009","volume":"29(3)","pages":"227-230","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813659/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7880,"authors":"Ahmed FE, Qureshi IM, Wooldridge MA, Pejaver RK.","articleTitle":"Hereditary spastic paraplegia and Evans's syndrome","bookWebsiteJournalTitle":"Acta Paediatr","date":"July 1996","volume":"85(7)","pages":"879-881","url":"http://www.ncbi.nlm.nih.gov/pubmed/8819560","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7881,"authors":"McLeod AG, Pai M, Carter RF, Squire J, Barr RD.","articleTitle":"Familial Evans syndrome: a report of an affected sibship.","bookWebsiteJournalTitle":"J Pediatr Hematol Oncol.","date":"May-June 1999","volume":"21(3)","pages":"244-247","url":"http://www.ncbi.nlm.nih.gov/pubmed/10363860","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15543,"phenoTypeName":"Thromboembolism","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9207,"phenoTypeName":"Arterial thrombosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10294,"phenoTypeName":"Petechiae","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8265,"phenoTypeName":"Bruising susceptibility","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5714,"phenoTypeName":"Epistaxis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8110,"phenoTypeName":"Gastrointestinal hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9809,"phenoTypeName":"Gingival bleeding","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10646,"phenoTypeName":"Cerebral hemorrhage","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15531,"phenoTypeName":"Abnormal bleeding","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13572,"phenoTypeName":"Platelet antibody positive","percentRanges":"-"}],"medicalProducts":[{"productId":695,"genericName":"Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified","tradeName":"Gammaked","tradeLink":"http://www.gammaked.com/","manufacturer":"","sponsor":"Kedrion Biopharma","indication":"The treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse, primary humoral immunodeficiency (PI) in patients 2 years of age and older, and idiopathic thrombocytopenic purpura (ITP) to raise platelet counts to prevent bleeding or to allow a patient with ITP to undergo surgery.","drugInformationLink":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c004331-7a91-8046-7510-9b9b7d33ced7","medlinePlusLink":""},{"productId":571,"genericName":"Human immunoglobulin (human)","tradeName":"Gammaplex","tradeLink":"http://www.gammaplex.com/","manufacturer":"","sponsor":"Bio Products Laboratory","indication":"In adults for treatment of chronic immune thrombocytopenic purpura (ITP) ","drugInformationLink":"http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c3ce068-59f0-413b-9f93-85fb597d55e5","medlinePlusLink":""},{"productId":466,"genericName":"Immune globulin injection [human], 10% caprylate/chromatography purified","tradeName":"Gamunex-C","tradeLink":"https://www.gamunex-c.com/en/hcp","manufacturer":"","sponsor":"Grifols","indication":"Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) to improve neuromuscular disability and impairment and for maintenance therapy to prevent relapse. Also for use for the treatment of primary immunodeficiency disease (PIDD) in patients 2 years of age and older and idiopathic thrombocytopenic purpura (ITP).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/gamunex-c","medlinePlusLink":""},{"productId":26,"genericName":"Romiplostim","tradeName":"Nplate","tradeLink":"https://www.nplate.com/","manufacturer":"","sponsor":"Amgen, Inc","indication":"December 2018, romiplostim (Nplate) received expanded approval for the treatment of thrombocytopenia in pediatric patients 1 year of age and older with ITP for at least 6 months who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Previously in August 2008, it was approved for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/nplate","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a609008.html"},{"productId":696,"genericName":"Immune globulin intravenous (human), 10% liquid","tradeName":"Privigen","tradeLink":"http://www.privigen.com/","manufacturer":"","sponsor":"CSL Behring","indication":"September 2017, immune globulin intravenous (human), 10% liquid (Privigen) was approved for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to improve neuromuscular disability and impairment, however it was not studied for use longer than 6 months. It was also approved for the treatment of patients age 15 years and older with chronic immune thrombocytopenic purpura (ITP) to raise platelet counts, and as replacement therapy for primary humoral immunodeficiency (PI).","drugInformationLink":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e5649da-75be-4a42-8eeb-4aeba562c401&audience=consumer","medlinePlusLink":""},{"productId":232,"genericName":"Eltrombopag","tradeName":"Promacta","tradeLink":"https://www.us.promacta.com/","manufacturer":"","sponsor":"GlaxoSmithKline","indication":"Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/promacta","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a609011.html"},{"productId":715,"genericName":"Fostamatinib disodium hexahydrate","tradeName":"Tavalisse","tradeLink":"http://tavalisse.com/","manufacturer":"","sponsor":"Rigel Pharmaceuticals, Inc.","indication":"April 2018 approved for  the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.","drugInformationLink":"","medlinePlusLink":""},{"productId":407,"genericName":"Rho (D) immunoglobulin intravenous (human)","tradeName":"WinRho SD","tradeLink":"http://www.winrho.com/","manufacturer":"Baxter ","sponsor":"Rh Pharmaceuticals, Inc.","indication":"Treatment of adults and children with chronic and acute immune thrombocytopenic purpura.","drugInformationLink":"http://dailymed.nlm.nih.gov/dailymed/search.cfm?startswith=winrho+SD","medlinePlusLink":""}],"EncodedName":"Idiopathic_thrombocytopenic_purpura"}